Dr Reddy’s Laboratories launches Redyx (remdesivir) in India
It is available in the strength of 100 mg vial
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Neovascularization inhibitor sales will near $7 bn in diabetic retinopathy market in 2029:…
This increase is expected to be driven by the demonstrable efficacy of these products in reducing the rate of angiogenesis and…
Cadila Pharma launches Obetocad, generic obeticholic acid for liver therapy
Obetocad can be used as a monotherapy or along with UDCA for treatment of patients with primary biliary cholangitis who are…
SIRO and AZIDUS enter into an alliance
The partnership will help expand services and market share for both the CROs
E-pharma set to revolutionise drug market access in India: GlobalData
E-pharma companies will offer competitive pricing and access to quality medicines even in remote places along with the ease of…
Takeda sells select non-core assets in Europe to Cheplapharm for about $562 mn
Portfolio includes prescription products in Takeda’s cardiovascular/metabolic and anti-inflammatory therapeutic areas along with…
Intravacc gets US NIAID contract to develop enterovirus D68 vaccine
EV D68 is a respiratory virus that can cause childhood paralysis, acute flaccid myelitis
Mylan to acquire thrombosis business in Europe from Aspen Pharmacare for EUR 641.9 mn
Transaction expected to be immediately accretive to Mylan upon closing and is anticipated to be accretive to VIATRIS
Dr Reddy’s Laboratories launches Fulvestrant Injection in US
Fulvestrant is an estrogen receptor antagonist indicated for the treatment of HR-positive advanced breast cancer
CORONA Remedies picks up stake in La Chandra Pharmalab
La Chandra Pharmalab is a manufacturer and supplier of pregnancy care drug progesterone and a range of hormone APIs
Janssen gets EC approval for expanded use of IMBRUVICA (ibrutinib) plus rituximab to treat CLL
Data from Phase 3 E1912 study showed previously untreated patients aged 70 years or younger treated with ibrutinib plus rituximab…
Hamdard Labs starts clinical trials of two drugs to evaluate efficacy to prevent COVID-19 infection
After regulatory approval from AYUSH ministry, the clinical trials are being conducted at HAH Centenary Hospital, New Delhi
Alembic Pharma gets tentative USFDA approval for Treprostinil injection
It is indicated for the treatment of pulmonary arterial hypertension to diminish symptoms associated with exercise
BPPI records sales turnover of Rs 146.59 cr in first quarter of 2020-21
The total sales up to July 31, 2020, stood at Rs 191.90 crores
Odisha gives in-principle nod for bulk drug park at Gopalpur
The cost of the infrastructure development in the park was estimated around Rs 1,500 crore
Lilly gets US FDA nod for additional doses of Trulicity (dulaglutide) to treat type 2 diabetes
The approval expands the label of once-weekly Trulicity to include 3.0 mg and 4.5 mg doses based on data from AWARD-11 trial
Roche’s Genentech gets US FDA approval for Gavreto (pralsetinib)
The drug is used to treat metastatic RET fusion-positive non-small cell lung cancer
BDR Pharma to launch 400 mg Favipiravir tablets
The 400 mg tablets will be priced at Rs 990 for a strip of 10 tablets
COVID-19 slashes pharma production in Uttarakhand
Hoping for revival, pharma units based in Haridwar plan to start 100 per cent production from next week
Sanofi impacted by disrupted clinical trials and lagging vaccine development due to COVID-19:…
Six of Sanofi’s clinical trials, which were being conducted in 31 countries, have been disrupted, which might impact the company's…